Neuraxis, INC (NRXS) stock
NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.87+0.26 (+5.64%)
Close on Nov 18, 2026Market cap $61.16MP/E –Yield –
Earnings
Neuraxis's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q4 FY2024
$800.00K
+50.5% on a year earlier
EPS, Q4 FY2024
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Neuraxis's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | Apr 21, 2026after the close | – | – | – | Filing |
| Q3 FY2025ended Sep 30, 2025 | Oct 23, 2025after the close | – | – | – | Filing |
| Q4 FY2024ended Dec 31, 2024 | Jan 8, 2025before the open | $800.00K | +50.5% | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024before the open | $667.00K | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 9, 2024before the open | $611.50K | -5.3% | – | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 9, 2024after the close | $531.50K | – | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Apr 9, 2024after the close | $531.50K | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Sep 21, 2023before the open | $646.00K | – | -$1.21 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Neuraxis has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Neuraxis puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Neuraxis filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- News
- Results
- Results
- Results
- Results
- Update
- Update
- News
- Results
- Results
- Update
- Update
- Update
See a number that looks wrong?